JP2008539271A5 - - Google Patents

Download PDF

Info

Publication number
JP2008539271A5
JP2008539271A5 JP2008509143A JP2008509143A JP2008539271A5 JP 2008539271 A5 JP2008539271 A5 JP 2008539271A5 JP 2008509143 A JP2008509143 A JP 2008509143A JP 2008509143 A JP2008509143 A JP 2008509143A JP 2008539271 A5 JP2008539271 A5 JP 2008539271A5
Authority
JP
Japan
Prior art keywords
cspcna
antibody
seq
isoform
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008509143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008539271A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/016096 external-priority patent/WO2006116631A2/en
Publication of JP2008539271A publication Critical patent/JP2008539271A/ja
Publication of JP2008539271A5 publication Critical patent/JP2008539271A5/ja
Pending legal-status Critical Current

Links

JP2008509143A 2005-04-27 2006-04-27 csPCNAイソ型抗体およびその使用 Pending JP2008539271A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67527505P 2005-04-27 2005-04-27
US68961405P 2005-06-09 2005-06-09
PCT/US2006/016096 WO2006116631A2 (en) 2005-04-27 2006-04-27 Cancer specific pcna isoform binding antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2008539271A JP2008539271A (ja) 2008-11-13
JP2008539271A5 true JP2008539271A5 (enExample) 2009-06-18

Family

ID=37215524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008509143A Pending JP2008539271A (ja) 2005-04-27 2006-04-27 csPCNAイソ型抗体およびその使用

Country Status (8)

Country Link
US (4) US20080206140A1 (enExample)
EP (1) EP1874823B1 (enExample)
JP (1) JP2008539271A (enExample)
AU (1) AU2006239318A1 (enExample)
CA (1) CA2605745A1 (enExample)
EA (1) EA200702361A1 (enExample)
MX (1) MX2007013584A (enExample)
WO (1) WO2006116631A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen
WO2007098415A2 (en) * 2006-02-17 2007-08-30 Indiana University Research And Technology Corporation Peptide based inhibition of capcna protein-protein interactions in cancer
JP2011529079A (ja) * 2008-07-24 2011-12-01 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション 癌のペプチド治療剤
US20120195978A1 (en) * 2009-10-07 2012-08-02 Indiana University Research And Technology Corpora Capcna peptide therapeutics for cancer
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
EP2688566A4 (en) * 2011-03-23 2014-09-10 Univ Indiana Res & Tech Corp THERAPEUTIC AGENTS AGAINST CANCER
CN112964883A (zh) 2014-03-24 2021-06-15 艾摩科诊断公司 用于全身性和非全身性自身免疫紊乱的改进的抗核抗体检测和诊断
US10420840B2 (en) 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
EP3555128B1 (en) 2016-12-15 2023-12-27 The National Institute for Biotechnology in the Negev Ltd. Anti-pcna monoclonal antibodies and use thereof
CN112638375A (zh) 2018-06-15 2021-04-09 旗舰创业创新五公司 通过后细胞信号传导因子的调节来增加免疫活性
EP3962493A2 (en) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor
WO2021127217A1 (en) 2019-12-17 2021-06-24 Flagship Pioneering Innovations V, Inc. Combination anti-cancer therapies with inducers of iron-dependent cellular disassembly
EP4172323A1 (en) 2020-06-29 2023-05-03 Flagship Pioneering Innovations V, Inc. Viruses engineered to promote thanotransmission and their use in treating cancer
KR20230165276A (ko) 2021-03-31 2023-12-05 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 타노트랜스미션 폴리펩티드 및 암의 치료에서의 이의 용도
AU2022303363A1 (en) 2021-06-29 2024-01-18 Flagship Pioneering Innovations V, Inc. Immune cells engineered to promote thanotransmission and uses thereof
US20240174732A1 (en) 2022-10-05 2024-05-30 Flagship Pioneering Innovations V, Inc. Nucleic acid molecules encoding trif and additional polypeptides and their use in treating cancer
US20240269251A1 (en) 2023-01-09 2024-08-15 Flagship Pioneering Innovations V, Inc. Genetic switches and their use in treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2305625A1 (en) * 1997-09-29 1999-04-08 University Of Maryland, Baltimore Altered dna synthesome components as biomarkers for malignancy
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen
EP1998177A3 (en) * 2003-01-06 2009-02-18 Wyeth Compositions and methods for diagnosing and treating colon cancers
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法

Similar Documents

Publication Publication Date Title
ES2434958T3 (es) Método para detectar cáncer ginecológico
JP2008539271A5 (enExample)
EP2900265B1 (en) Anti-uroplakin ii antibodies systems and methods
US9840551B2 (en) Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
JP2009528507A (ja) Reg4タンパク質を用いて膵癌を診断する方法
AU2011239583A1 (en) Monoclonal antibodies against HER2 antigens, and uses therefor
JP6074676B2 (ja) 組織因子経路阻害因子2(tfpi2)測定による卵巣明細胞腺癌の検査方法および検査薬
CN108064343B (zh) 用于前列腺癌分析的组合物和方法
WO2014144060A1 (en) Monoclonal antibodies to transferrin and transferrin receptor antigens, and uses thereof
US9625461B2 (en) Method of detecting cancer using delta-catenin
JP2008539271A (ja) csPCNAイソ型抗体およびその使用
EP2615110A1 (en) Biomarker for diagnosing cancer and method of isolating cancer cell using the same
JP2010502192A (ja) Borisアイソフォーム並びに疾患を検出及び治療する方法
KR101439856B1 (ko) 항-atic 자가면역항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물
CN103842503A (zh) 上皮性卵巢癌标志物检测用抗体和上皮性卵巢癌判定方法
US9663567B2 (en) Monoclonal antibodies against serotransferrin antigens, and uses therefor
EP2707720A2 (en) Diagnosis and prognosis of triple negative breast and ovarian cancer
US20240239846A1 (en) Methods of analysing a sample
Cressey et al. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients
WO2021246153A1 (ja) 膵臓がんの検出方法及び検出試薬
JP6729917B2 (ja) EphA2 N末端フラグメント抗体
JP2010180168A (ja) 胆管癌特異的糖鎖エピトープを認識するモノクローナル抗体
US20130143231A1 (en) MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY
CN102597772B (zh) 5.9kDa肽的免疫学测定方法
CN103842504A (zh) 上皮性卵巢癌标志物检测用抗体和上皮性卵巢癌判定方法